Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk to begin selling it in the world’s second-largest economy, where the appetite for similar treatments is surging.
Related Posts
Canada Approves Bunge’s $8.2 Billion Deal for Viterra
- staff
- January 15, 2025
- 0
Canada has approved Bunge’s $8.2 billion deal for Glencore-backed Viterra, as the companies agreed to concessions to address previous antitrust concerns.
How Safe Am I Online?—and Other Questions Readers Asked About Cybersecurity
Should I use incognito mode? How risky are public Wi-Fi networks? Should I use a VPN? And more.
X Names New CFO as Musk Shifts Focus to Trump Administration
Mahmoud Reza Banki, former Tubi finance chief, joins platform amid financial challenges.